ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

Reorganization Of Making Program Is Proposed

June 22, 1990

Conversation with Walter Curran – Proton Therapy: What’s Known and What’s Not

October 25, 2013

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991